Application of the French prognostic score (FPS) to assess overall survival (OS) in a U.S.-based cohort of patients (pts) treated with azacitidine (Aza).
Amer Zeidan
No relevant relationships to disclose
Zhuoxin Sun
No relevant relationships to disclose
Thomas Prebet
Research Funding - Celgene
Peter Greenberg
No relevant relationships to disclose
Mark Juckett
No relevant relationships to disclose
Mitchell Reed Smith
No relevant relationships to disclose
Elisabeth Paietta
No relevant relationships to disclose
Janice Lynn Gabrilove
No relevant relationships to disclose
Harry P. Erba
No relevant relationships to disclose
Steven Gore
Research Funding - Celgene
Martin S. Tallman
No relevant relationships to disclose